Sign in

CIK 0001287098

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MAXCYTE, INC.

Sign in to watch
Ticker
MXCT
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
522210438
Phone
+1 301-517-5556
Business address
9713 KEY WEST AVENUE,, SUITE 400, ROCKVILLE, MD, 20850
Former names
MAXCYTE INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Planned sale President and CEO sold 43,851 shares at an average $5.04 ($220,859)
  9. 4 Planned sale President and CEO sold 16,149 shares at $5.02 ($81,068)
  10. 4 Planned sale EVP, Global Sales & Marketing sold 14,134 shares at $5.00 ($70,670)
  11. 4 Planned sale President and CEO sold 15,000 shares at $5.00 ($75,000)
  12. 4 Planned sale EVP, Global Sales & Marketing sold 34,160 shares at an average $5.02 ($171,616)
  13. 4 Planned sale President and CEO sold 34,823 shares at an average $5.02 ($174,951)
  14. 4 Planned sale EVP, Global Sales & Marketing sold 9,973 shares at an average $5.02 ($50,084)
  15. 4 Planned sale President and CEO sold 10,177 shares at an average $5.02 ($51,110)
  16. 4 Open-market buy Director bought 80,000 shares at $4.32 ($345,480)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 9 · 163 filings